Business Context and Reporting Period
Company: Alpha Pro Tech, Ltd.
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter ended March 31, 2004
Business Overview: The Company manufactures and distributes disposable protective apparel, infection control products (masks/shields), extended care products, and consumer products (pet beds). Primary markets include pharmaceutical, industrial safety, medical, and dental sectors, with distribution predominantly in the United States.
Key Financial Metrics
| Metric | Q1 2004 | Q1 2003 |
|---|---|---|
| Net Sales | $5,853,000 | $5,356,000 |
| Gross Margin | $2,990,000 (51.1%) | $2,726,000 (50.9%) |
| Net Income | $467,000 | $465,000 |
| Diluted EPS | $0.02 | $0.02 |
| Cash and Equivalents | $2,800,000 | $2,449,000 |
| Working Capital | $11,026,000 | N/A |
| Total Debt | $0 | $0 |
| Net Cash Used in Operating Activities | ($793,000) | ($62,000) |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 9.3% ($497,000) year-over-year, driven primarily by a 17.9% increase in the Apparel segment due to pharmaceutical industry demand.
- Segment Performance: While Apparel grew significantly, the Mask and Shield segment declined 9.1% ($121,000) due to lower N-95 respirator sales compared to the SARS outbreak period in Q1 2003. Extended Care sales remained flat.
- Expense Increases: Selling, General, and Administrative (SG&A) expenses rose 13.3% ($248,000), largely due to increased sales and marketing investments ($161,000) and payroll costs. This offset the increase in gross profit, resulting in flat net income.
- Cash Flow: Net cash used in operating activities increased significantly to $793,000 from $62,000 in the prior year, primarily due to higher accounts receivable and reduced accounts payable/accrued liabilities.
Guidance, Outlook, and Risks
- Outlook: Management expects gross profit margins to remain at approximately 51% for the balance of 2004. They anticipate that recent investments in sales and marketing will yield improved sales growth in coming quarters.
- Capital Expenditures: The Company expects to purchase an additional $450,000 of equipment in 2004.
- Liquidity: The Company is debt-free with a $3.5 million credit facility (currently $2.91 million available). Management believes current cash and credit facilities are sufficient for working capital and planned expenditures.
- Risks: Operations are exposed to foreign currency exchange rate fluctuations due to manufacturing in Mexico and China. The Company does not hedge these risks. Forward-looking statements are subject to risks regarding market acceptance and economic conditions.
Investor Verification Checklist
- Cash Flow vs. Net Income: Verify the sustainability of operations given the significant divergence between positive net income ($467k) and negative operating cash flow ($793k).
- Accounts Receivable: Review the $370,000 increase in accounts receivable to ensure collection trends remain healthy.
- SG&A Efficiency: Monitor whether the increased sales and marketing spend ($161k increase) translates into proportional revenue growth in subsequent quarters.
- Segment Mix: Assess the long-term viability of the Apparel segment's growth versus the decline in the Mask and Shield segment post-SARS.
- Inventory Levels: Note the decrease in inventory ($258k reduction) and ensure it aligns with sales demand to avoid stockouts.